Complementary Vascular and Matrix Regulatory Pathways Underlie the Beneficial Mechanism of Action of Sorafenib in Liver Fibrosis
Hepatology - United States
doi 10.1002/hep.24427
Full Text
Open PDFAbstract
Available in full text
Date
June 26, 2011
Authors
Publisher
Wiley